Abstract
The concept and application of ethical principles in the context of medical research is changing rapidly. This is especially true for fast moving fields such as gene therapy, a relatively new but rapidly maturing field offering opportunities to influence health at a fundamental level, which may become a cornerstone of medicine. By 2004, over 700 gene therapy clinical protocols had been initiated worldwide, and two highly publicized gene therapy-related side effects have helped to shape recent ethical debate. These events have influenced not only clinical trial design but also public opinion and systems of independent oversight. Both the science of gene therapy and the regulatory environment are continually evolving. How well the field is able to respond to these challenges will determine the extent to which gene therapy will ultimately be integrated into medical practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Williams DA, Baum C . Gene therapy – new challenges ahead. Science 2003; 302: 400–401.
Li Z et al. Murine leukemia virus induced by retroviral gene marking. Science 2002; 296: 497.
Recommendations of the GTAC/CSM working party on retroviruses. April 2003. http://www.advisorybodies.doh.gov.uk/genetics/gtac/.
Report by the Director-General on the possibility of elaborating universal norms on bioethics. 22 September 2003. 32C/59.
Our Inheritance, Our Future. Health Departments of the United Kingdom, London. Cm 5791-11. 2003. ISBN 0-10-157912-8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spink, J., Geddes, D. Gene Therapy Progress and Prospects: Bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment. Gene Ther 11, 1611–1616 (2004). https://doi.org/10.1038/sj.gt.3302354
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302354
Keywords
This article is cited by
-
Will rising prices and budget constraints prevent patients from accessing novel gene therapies?
Gene Therapy (2017)
-
The ethics of human gene transfer
Nature Reviews Genetics (2008)